This site is best viewed with Internet Explorer 8 or greater, or Firefox 3.5 or greater. Click the icon below to upgrade to a suitable browser version.


Close

PanCan news



Syndicate content pancreatic cancer - Google News
Google News
Updated: 22 hours 41 min ago

10 Signs Of Pancreatic Cancer You Should Never, Ever Ignore - Women's Health

Thu, 2018-01-25 14:56

Women's Health

10 Signs Of Pancreatic Cancer You Should Never, Ever Ignore
Women's Health
Your pancreas is one of those organs you probably don't think about much. Just six inches long and tucked away behind your stomach, its main job is to help you digest your food and control your blood sugar. Normally it does its work seamlessly, behind ...

Researchers modify common flu virus to attack pancreatic cancer - Medical Xpress

Wed, 2018-01-24 19:00

Medical Xpress

Researchers modify common flu virus to attack pancreatic cancer
Medical Xpress
Maggie Blanks, CEO of Pancreatic Cancer Research Fund said: "It's exciting to see research we've funded at Barts Cancer Institute since 2009 - both in modifying viruses as a potential treatment for pancreatic cancer and progressing knowledge about ...

and more »

FDA OKs accelerated approval pathway for AngioDynamics ... - Seeking Alpha

Wed, 2018-01-24 16:31

FDA OKs accelerated approval pathway for AngioDynamics ...
Seeking Alpha
AngioDynamics (NASDAQ:ANGO) is up 1% after hours in response to its announcement that the FDA has granted Expedited Access Pathway (EAP) status for its NanoKnife System for the treatment of Stage III (cancer has spread, but not metastasized) pancreatic ...

and more »

Pancreatic Cancer Trial Data Will Be Released Soon - Streetwise Reports

Wed, 2018-01-24 14:23

Streetwise Reports

Pancreatic Cancer Trial Data Will Be Released Soon
Streetwise Reports
A biotech company that has begun clinical testing of human antibodies to treat cancers is in discussion with potential partners.
The Pancreatic Cancer Action Network Urges All Pancreatic Cancer ...New Kerala

all 2 news articles »

Grants Roundup: $25 Million for Pancreatic Cancer Research; $10 Million for Bush Library - The Chronicle of Philanthropy

Wed, 2018-01-24 10:09

The Chronicle of Philanthropy

Grants Roundup: $25 Million for Pancreatic Cancer Research; $10 Million for Bush Library
The Chronicle of Philanthropy
A $10 million grant to the George W. Bush Presidential Center will endow a series of public lectures and forums featuring authors and other thought leaders. Here are notable new grant awards compiled by The Chronicle: Skip Viragh Foundation. $25 ...

Nomogram for predicting survival in patients with pancreatic cancer - Dove Medical Press

Tue, 2018-01-23 19:24

Nomogram for predicting survival in patients with pancreatic cancer
Dove Medical Press
Background: The purpose of this study was to develop a nomogram to predict cancer-specific survival (CSS) in pancreatic cancer (PC). Patients and methods: We used the Surveillance, Epidemiology, and End Results (SEER) database to analyze 53,028 ...

FDA grants orphan drug designation to BPM31510 for pancreatic cancer - Healio

Tue, 2018-01-23 16:04

FDA grants orphan drug designation to BPM31510 for pancreatic cancer
Healio
The FDA granted orphan drug designation to BPM31510 for the treatment of pancreatic cancer, according to the agent's manufacturer. BPM31510 (BERG) targets the dysregulated metabolism in cancer cells by re-engaging the mitochondria to generate energy ...

FDA Grants Orphan Drug Designation to Pancreatic Cancer Treatment - Rare Disease Report

Tue, 2018-01-23 10:42

Rare Disease Report

FDA Grants Orphan Drug Designation to Pancreatic Cancer Treatment
Rare Disease Report
Biopharmaceutical company BERG announced this morning that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its leading product candidate BPM31510 (ubidecarenone) for the treatment of pancreatic cancer. The potential ...

Pancreatic cancer combo sees high survival rates in ChemoCentryx ... - Endpoints News

Tue, 2018-01-23 09:53

Endpoints News

Pancreatic cancer combo sees high survival rates in ChemoCentryx ...
Endpoints News
A Mountain View company is posting early data from a pancreatic cancer drug program, in which its immunotherapy and chemotherapy combo significantly outperformed chemo on its own. The clinical-stage company, called ChemoCentryx $CCXI, shared patient ...
ChemoCentryx eyes combinations after posting pancreatic cancer OS dataFierceBiotech

all 3 news articles »

Let's Win Launches Online Video Series Featuring Long-Term ... - PR Newswire (press release)

Tue, 2018-01-23 09:09

Let's Win Launches Online Video Series Featuring Long-Term ...
PR Newswire (press release)
NEW YORK, Jan. 23, 2018 /PRNewswire/ -- Let's Win, an initiative supported by the Lustgarten Foundation, launched the Let's Win! Pancreatic Cancer Survivors video series Friday, January 19, 2018, at the American Society of Clinical Oncology ...

and more »

ChemoCentryx eyes combinations after posting pancreatic cancer ... - FierceBiotech

Tue, 2018-01-23 08:12

FierceBiotech

ChemoCentryx eyes combinations after posting pancreatic cancer ...
FierceBiotech
ChemoCentryx has posted 18-month survival data from a phase 1b trial of one of its CCR2 inhibitors in pancreatic cancer patients. Almost 30% of the participants were still alive 18 months after starting treatment on a combination of CCX872 and the ...
Pancreatic cancer combo sees high survival rates in ChemoCentryx ...Endpoints News

all 3 news articles »

Smartphone app helps screen for pancreatic cancer - Healio

Tue, 2018-01-23 08:09

Smartphone app helps screen for pancreatic cancer
Healio
Researchers at University of Washington have developed a smartphone app designed to detect jaundice, a common early symptom of pancreatic cancer. Investigators assessed the use of a novel app called BiliScreen, intended to capture pictures of a person ...

TGen, HonorHealth use zebrafish to help fight pancreatic cancer - FOX 10 News Phoenix

Tue, 2018-01-23 00:00

FOX 10 News Phoenix

TGen, HonorHealth use zebrafish to help fight pancreatic cancer
FOX 10 News Phoenix
We're talking about zebrafish. They're about 2 inches long and a creature best known as an aquarium pet. Thanks to research right here in Phoenix, they may also hold the key to surviving one of the most deadliest forms of cancer. "I was diagnosed ...

ChemoCentryx Announces Positive Overall Survival Results with ... - GlobeNewswire (press release)

Mon, 2018-01-22 17:00

ChemoCentryx Announces Positive Overall Survival Results with ...
GlobeNewswire (press release)
MOUNTAIN VIEW, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq:CCXI), announced today positive overall survival (OS) results from an ongoing Phase Ib clinical trial of the Company's second CCR2 inhibitor – CCX872 – in the ...

and more »

Nab-Paclitaxel/Gemcitabine Induces Encouraging Responses in Locally Advanced Pancreatic Cancer - Targeted Oncology

Mon, 2018-01-22 12:29

Targeted Oncology

Nab-Paclitaxel/Gemcitabine Induces Encouraging Responses in Locally Advanced Pancreatic Cancer
Targeted Oncology
“Since its approval to treat metastatic pancreatic cancer in 2013, the Abraxane plus gemcitabine regimen has become a standard of care in first-line metastatic pancreatic cancer,” Nadim Ahmed, president, Hematology and Oncology for Celgene, the company ...





Login

Connect with FaceBook


Website designed and developed by Uru Multimedia, and hosted by Chrysalis Hosting